Literature DB >> 12699753

Preparation and pharmacological profile of 7-(alpha-azolylbenzyl)-1H-indoles and indolines as new aromatase inhibitors.

Pascal Marchand1, Marc Le Borgne, Martina Palzer, Guillaume Le Baut, Rolf W Hartmann.   

Abstract

Aromatase (P450 arom) is a target of pharmacological interest for the treatment of breast cancer. New series of 7-(alpha-azolylbenzyl)-1H-indoles and indolines were synthesized as non-steroidal inhibitors of P450 arom. Selectivity was studied towards P450 17alpha enzyme. The most active compound, 1-ethyl-7-[(imidazol-1-yl)(4-chlorophenyl)methyl]-1H-indole 12c exhibited promising relative potency (rp) of 336 (rp of aminoglutethimide=1) and most of the described azoles were active and selective towards P450 arom.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12699753     DOI： 10.1016/s0960-894x(03)00182-3

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN： 0960-894X            Impact factor:   2.823


  7 in total

1.  Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives.

Authors:  Kevin Bonfield; Erica Amato; Tony Bankemper; Hannah Agard; Jeffrey Steller; James M Keeler; David Roy; Adam McCallum; Stefan Paula; Lili Ma
Journal:  Bioorg Med Chem       Date:  2012-02-27       Impact factor: 3.641

Review 2.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

3.  Docking and 3D-QSAR studies of diverse classes of human aromatase (CYP19) inhibitors.

Authors:  Partha Pratim Roy; Kunal Roy
Journal:  J Mol Model       Date:  2010-03-01       Impact factor: 1.810

4.  Structure-activity relationships and docking studies of synthetic 2-arylindole derivatives determined with aromatase and quinone reductase 1.

Authors:  Allan M Prior; Xufen Yu; Eun-Jung Park; Tamara P Kondratyuk; Yan Lin; John M Pezzuto; Dianqing Sun
Journal:  Bioorg Med Chem Lett       Date:  2017-11-06       Impact factor: 2.823

5.  2-[(1H-Imidazol-1-yl)meth-yl]-1-[4-(trifluoro-meth-yl)phen-yl]-1H-indole.

Authors:  Rui Wang; Hong-Fan Shi; Lin Du; Jing-Feng Zhao; Jian-Ping Liu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-03-17

6.  3-Pyridyl substituted aliphatic cycles as CYP11B2 inhibitors: aromaticity abolishment of the core significantly increased selectivity over CYP1A2.

Authors:  Lina Yin; Qingzhong Hu; Rolf W Hartmann
Journal:  PLoS One       Date:  2012-11-01       Impact factor: 3.240

7.  Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols.

Authors:  Nicolas Lebouvier; Fabrice Pagniez; Young Min Na; Da Shi; Patricia Pinson; Mathieu Marchivie; Jean Guillon; Tarek Hakki; Rita Bernhardt; Sook Wah Yee; Claire Simons; Marie-Pierre Lézé; Rolf W Hartmann; Angélique Mularoni; Guillaume Le Baut; Isabelle Krimm; Ruben Abagyan; Patrice Le Pape; Marc Le Borgne
Journal:  Pharmaceuticals (Basel)       Date:  2020-08-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.